WHO grants first mpox vaccine approval to ramp up response to disease in African countries hit the hardest

By Vuyile Madwantsi | Published Sep 17, 2024

WHO approved the two-dose vaccine for adults aged 18 and above. While the vaccine is not recommended for those under 18, WHO noted that it could be used in infants, children, and adolescents in areas experiencing outbreaks where the benefits of vaccination outweighed the risks.